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Abstract
Salivary glands are considered the chief exocrine glands of the mouth and physiologically contribute to the maintenance of 
the homeostasis of the oral cavity. They consist of the parotid, submandibular and sublingual glands, which come in pairs 
and are collectively called the major glands, and the minor glands, which are much smaller and are dispersed throughout the 
buccal cavity. Salivary glands are distinguished by their size, amount of saliva secretion and their location in the oral cavity. 
Salivary glands pathophysiology has been a subject of interest in various worldwide metabolic disorders, including diabetes 
mellitus. Diabetes mellitus (DM), a global health concern, with a pathological imprint involved in vasculature, promotes 
microvascular and macrovascular complications among which periodontitis ranks sixth. Indeed, DM has also been directly 
associated with oral health lesions. Specifically, salivary glands in the context of diabetes have been a focal point of study 
and emphasis in the research field. There is evidence that relates salivary secretion content and diabetes progression. In this 
review, we present all the reported evidence of the deregulation of specific salivary proteins associated with the progression 
of diabetes in parallel with changes in salivary gland morphology, cellular architecture, and salivary secretion and composi-
tion more generally.
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Introduction
Anatomically, the salivary glands constitute a system of exo-
crine glands localized in the head, in and around the buccal 
cavity. Under physiological conditions, salivary contents are 
released through a system of ducts into the mouth. Salivary 
gland secretions contribute to oral health by keeping the 
oral mucosa protected and lubricated (Contreras-Aguilar 
and Gómez-García 2020). They are also responsible for ini-
tiating early stages of digestion in the oral cavity by two 
mechanisms: (1) assisting in the creation of a food bolus 
during the mastication procedure thus allowing its swallow-
ing for further processing; (2) through their enzymatic con-
tent, namely alpha-amylase, which breaks down starch into 
maltose and glucose. The glands are differentiated by their 
size and are classified based on the type of the saliva they 
excrete (Basset et al. 2020a). Diabetes Mellitus (DM) is a 
growing global health concern that impacts the global health 
expenditure. DM is classified into type 1 (T1DM) and type 
2 diabetes (T2DM). The former is referred to as “juvenile” 
diabetes in which it occurs at a young age and is mediated by 
an autoimmune destruction of the insulin-producing β cells 
of the pancreas; while the latter pertains to cellular insulin 
resistance and is statistically prevalent (Kudiyirickal and 
Pappachan 2015). DM is usually accompanied by a plethora 
of complications, including oral health diseases (Saini et al. 
2011; Zhang et al. 2014). Recently, a body of evidence has 
shed light on the importance of oral complications in DM 
patients and underlined their interconnection (Kudiyirickal 
and Pappachan 2015). In this review, we present findings 
that underpin the correlation between DM and salivary gland 
complications, specifically the alterations of key proteins 
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in diabetic patients that gravely moderate the function of 
salivary glands and ultimately impact patients daily lifestyle.
Salivary gland diseases and Diabetes 
Mellitus
Salivary Glands physiology and anatomy
The salivary glands are classified into two main 
groups: minor and major. The major glands are much larger 
in size and account for most of the salivary secretions, a 
function directly linked to their histology and morphology 
as they consist of a collection of exocrine tissues that secrete 
as a whole into a salivary duct rather than acting individu-
ally. Minor and major salivary glands not only differ by 
the amount of saliva they produce but also by the quality 
of salivary secretions. Minor gland saliva serves to lubri-
cate the walls of the oral cavity, while major gland saliva 
is digestive and protective in nature. There are three pairs 
of major salivary glands that open into the mouth through 
distinctive ducts. The parotid salivary glands, the largest of 
the three, are enclosed in a tissue capsule and are composed 
of fat tissue and cells. They mainly produce serous fluids 
which account for approximately 25–30% of the total daily 
salivary output. Each gland’s main duct, called Stensen’s 
duct, opens in the rear of the mouth cavity near the second 
upper molar. The second pair, the submandibular glands, are 
located along the side of the lower jawbone, these glands 
are surrounded by a capsule of tissue which give off mixed 
secretions mostly serous in nature. It secretes by far the larg-
est volume of saliva of all roughly 70% of the total daily 
output. The Wharton’s duct of each of those glands opens 
into the floor of the mouth at the junction where the front 
of the tongue meets the mouth’s floor. The third pair are the 
smallest in size, the sublingual glands, located beneath the 
mucous membrane of the floor of the mouth, near the chin 
region. These are dispersed throughout the surrounding tis-
sues since they are not encapsulated as the aforementioned 
glands. Their numerous Rivinus’s ducts empty near the 
junction of the tongue and the mouth’s floor while some of 
them fuse to form Bartholin’s duct, the main duct of the sub-
lingual gland, which discharges into the submaxillary duct. 
These glands secrete a mixed fluid that is mainly mucus 
which accounts for only 5% of the total daily salivary output 
(Holmberg and Hoffman 2014; Kessler and Bhatt 2018).
Minor salivary gland tissue is approximately comprised 
of 800–1000 small salivary glands dispersed as patches 
throughout the submucosa of the sino nasal cavity, oral cav-
ity, pharynx, larynx, trachea, lungs, and middle ear cavity. 
Minor salivary glands produce roughly 1% or less of the 
total salivary output. Although minor salivary gland tissue 
can be found anywhere along the aerodigestive tract, it is 
most condensed along the labial mucosa, lingual mucosa, 
buccal mucosa, the soft palate, the lateral parts of the hard 
palate, and the floor of the mouth (Holmberg and Hoffman 
2014).
Saliva has several major functions within the oral cav-
ity which involve buffering, lubrication, antimicrobial job, 
digestion, hormone regulation and taste sensation. Saliva is 
composed of 99.5% water and 0.5% of glycoproteins, mucus, 
electrolytes, enzymes and antibacterial composites. Humans 
produce between 0.5 to 1.5 L of saliva every day. This secre-
tion is initiated by parasympathetic stimulation; the neuro-
transmitter activated in this process is acetylcholine in which 
it binds to the muscarinic receptors in the gland, leading 
to amplified salivation (Holmberg and Hoffman 2014). The 
process in which saliva is formed is composed of two phases: 
(1) During phase one, salivary secretions are formed in the 
acinar cells (serous and/or mucus cells) within the rough 
endoplasmic reticulum by ribosomal protein synthesis and 
are stored as granules. These granules are later discharged 
into the lumen by exocytosis. (2) In the second phase, the 
saliva is subdued to chemical changes while passing through 
the salivary ductal system as it reaches the oral cavity. As 
it reaches the intercalated ducts, isotonic saliva secreted by 
the acini is mixed with lysozymes and lactoferrin produced 
by the intercalated duct cells. In the striated ducts, reabsorp-
tion of chloride and sodium takes place concomitantly with 
kallikrein and epidermal growth factor release and since 
these ducts are impermeable to water, the final outcome is 
a hypotonic state of saliva ready to be released into the oral 
cavity through the excretory ducts (Romanenko et al. 2008; 
Punj 2019; Contreras-Aguilar and Gómez-García 2020). 
Myoepithelial cells participate in the flow and secretion of 
saliva by providing contractile support to the acinar cells 
and the intercalated ducts (Proctor 2016). Through secre-
tions and exocytosis-mediated release by the acinar cells as 
well as the flow of saliva into the ducts, salivary proteins 
such as proline-rich proteins, histatins, cystatin, defensins, 
cathelicidin-LL37, and enzymes such as amylase (ptyalin), 
peroxidase and lysozyme are being released and mixed into 
the saliva constituting the bulk of salivary proteins (Proctor 
2016).
Diabetes and oral manifestations are intertwined
As mentioned previously, DM is usually accompanied 
by a plethora of complications, including oral health dis-
eases (Kudiyirickal and Pappachan 2015). Periodontitis 
was ranked sixth among those complications (Saini et al. 
2011). DM and periodontal complications have a mutually 
reinforcing effect on each other: DM increases the ruthless-
ness, occurrence and progression of periodontal disease 
while periodontal disease may accentuate the severity of 
DM by deteriorating the level of glycemic control in the 
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blood (Meenawat et al. 2013). Moreover, studies have shown 
that periodontal inflammation is significantly increased in 
subjects with longer disease course, poor metabolic con-
trol (Arana et al. 2017) and DM complications (Preshaw 
et al. 2012). This makes it more dominant in T1DM patients 
whereas T2DM are more prone to develop tumors at differ-
ent sites, including the salivary glands (Suba et al. 2005). 
This is in contrast with xerostomia (hyposalivation) that has 
been shown to be prominent in both types of DM (Hoseini 
et al. 2017).
Salivary gland diseases in diabetes
A plethora of disease processes can occur within salivary 
gland tissue. Their prevalence depends on various aetio-
logical factors. Common infectious/inflammatory pro-
cesses within the major and minor salivary glands have been 
reported. These may include bacterial, viral infections, rarely 
fungal and ductal obstruction which may cause agonizing 
swelling or blockage, affecting their function (Kessler and 
Bhatt 2018). Although scarce, salivary glands may also be 
affected of benign and malignant tumors classified under 31 
different types (El-Naggar et al. 2017). In addition, recent 
research has shed light on the strong association between 
salivary gland diseases and DM, a major growing public 
health concern as one of the leading causes of mortality and 
morbidity globally (Rohani 2019).
DM is associated with enhanced periodontal tissue 
destruction, which requires from DM patients an extreme 
management of periodontal disease and rapid control of 
ongoing infections to avoid exacerbation of the existing 
metabolic imbalance (Rohani 2019). On the cellular and 
molecular levels, particularly, the oral cavity and associated 
structures remains a somewhat under‐examined area in dia-
betes mellitus research. Studying salivary gland dysfunc-
tion markers and protein expression in DM patients may 
hold a great potential for increasing our understanding of 
the pathophysiology of this multifactorial disease. Using 
proteomics-based technologies for detecting salivary gland 
hallmark proteins in diabetic patients is definitely a prom-
ising tool for detecting pathological abnormalities prior to 
development of clinical symptoms.
The role of oxidative stress in diabetes‑related oral 
disease
Chronic oxidative stress is a state that occurs in DM due to 
persistent hyperglycemia, which stimulates a sequence of 
mechanisms that generate excessive production of reactive 
oxygen species (ROS). In addition, it has been well estab-
lished that ROS overproduction is involved in mediating a 
state of oxidative stress being the final pathway responsible 
for the onset and progression of DM complications (Giacco 
and Brownlee 2010). Taking in account the importance of 
oxidative stress in driving the onset and progression of DM 
complications, and periodontitis being ranked sixth among 
DM complications (Saini et al. 2011), we ought to pinpoint 
its importance in diabetes-related oral manifestations. ROS 
are highly reactive chemical molecules that when increased 
dramatically under stressful conditions lead to significant 
damage of cellular structures especially in the case of weak-
ened antioxidant systems (Knaś et al. 2016). Different oxida-
tive stress markers such as 8-Hydroxy-2′-deoxyguanosine 
(8-OHdG), protein carbonyl (PC), 4-hydroxynonenal 
protein adduct (4-HNE), oxidized and/or MDA-modified 
LDL-cholesterol (oxy-LDL/MDA) and 8-isoprostanes 
(8-isoP) were measured in streptozotocin (STZ)-induced 
DM rats (Knaś et al. 2016). Furthermore, this study evalu-
ated oxidative damage caused to the salivary glands in STZ-
induced DM. Results showed the three major salivary glands 
undergo increased oxidative stress in STZ rats regardless 
of the duration of the disease. However, the parotid glands 
seemed more vulnerable showing greater extent and diver-
sity of oxidative injury in this gland. Moreover, decrease of 
the stimulated saliva secretion is detected in the first week 
of the experiment. In the progressive stages of the disease, 
simulated saliva secretion is significantly more reduced than 
the secretion of non-stimulated saliva (Knaś et al. 2016). 
Another study has shown similar results pertaining to the 
role of oxidative stress (OS) in the pathogenesis of the sali-
vary gland dysfunction in the course of insulin resistance 
(IR) in high fat diet (HFD) fed rats (Kolodziej et al. 2017). 
Results revealed increased oxidative stress markers in IR 
rats compared to control as well as significant decrease in 
stimulated salivary flow rate. But most importantly, IR is a 
prediabetic state and subsequently, salivary gland dysfunc-
tions could be identified early in the progressive course of 
this disease and could be also detected in prediabetic state. 
Thus, IR should be taken seriously in dental clinics as at 
this stage of DM it could lead to oral health manifestations 
(Kolodziej et al. 2017). Oxidative stress marker, oxidized 
glutathione/reduced glutathione (GSSG/GSH), was shown 
to be increased in the saliva of T2DM patients compared 
to control group (Arana et al. 2006, 2017). Additionally, a 
significant increase in oxidative stress levels was found in 
the T2DM group with poor metabolic control vs the T2DM 
group with good metabolic control. This increase in oxi-
dative stress was positively correlated with poor periodon-
tal health as the Community Periodontal Index (CPI) was 
the highest in T2DM group with poor metabolic control as 
compared with T2DM group with good metabolic control 
and the control group respectively (Arana et al. 2017). An 
increase in total antioxidant power (TAOP) was reported in 
the saliva of T1DM patients compared to the control (Asta-
neie et al. 2005). A similar study reported the correlation 
between the increase in salivary and serum total antioxidant 
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status (TAS), superoxide dismutase (SOD) and oxidative 
stress with the severity of DM/HbA1c values (Reznick et al. 
2006). On the other hand, a decrease in salivary superox-
ide dismutase (SOD) of T1DM patients was presented as a 
possible driving factor of oral complications of DM (Belce 
et al. 2000). Taken together, these data encourage the evalu-
ation of alterations of oxidative parameters in saliva of DM 
patients as it may be a non-invasive alternative for achieving 
a better understanding of the pathogenesis of the disease.
Deregulation of Salivary gland protein expression 
in diabetes mellitus
Salivary amylase protein alteration in Diabetes
Alterations in salivary parameters of DM patients have been 
associated with changes in their metabolism afflicted by DM. 
One of the most studied salivary parameters is salivary amyl-
ase protein. Salivary amylase protein is a prominent protein 
found in the oral cavity (Pérez-Ros et al. 2021). Lately, sali-
vary proteins as potential markers for diagnosis and prog-
nosis of chronic disease have been a hot topic of research 
as they offer various advantages due to their ease of col-
lection, less risks of infections, lower cost and mainly their 
non-invasive nature. In this context, salivary amylase levels 
have been studied in DM patients. A significant increase in 
salivary amylase in DM patients compared to controls under 
fasting (López et al. 2003; Aydin 2007; Abd-Elraheem et al. 
2017) and non-fasting (Malathi et al. 2013; Priya et al. 2016; 
Lima-Aragão et al. 2016; Lodgotra et al. 2016; Tiongco et al. 
2019; Kheirmand Parizi et al. 2019) conditions has been 
reported; albeit other scientist groups have shown differ-
ent outcomes (Tenovuo et al. 1986; Newrick et al. 1991; 
Panchbhai et al. 2010; Prathibha et al. 2013; Indira et al. 
2015), Table 1. Results are also rather conflicting when it 
comes to the correlation between blood and salivary glucose/
amylase levels (Panchbhai et al. 2010; Siddiqui et al. 2015; 
Abd-Elraheem et al. 2017; Tiongco et al. 2019). Salivary 
amylase levels are certainly worth further investigations in 
DM patients, however for the time being, no decisive conclu-
sion can be elaborated about their use as a substitute marker 
to blood glucose for screening DM patients.
Sodium‑glucose cotransporter 1 (SGLT1)
In recent studies it has been found that levels of fasting and 
postprandial blood glucose are drastically higher among DM 
patients with oral manifestations compared to those without, 
indicating inadequately controlled glycemic status, there-
fore demanding earlier evaluation of oral manifestations to 
detect long-term complications (Bajaj et al. 2012). Due to 
major association between DM patients with oral manifesta-
tions and other diseases such as retinopathy, hypertension, 
peripheral and autonomic neuropathy, deregulation of spe-
cific common proteins expression has been investigated. 
A prominent example is the high level of sodium-glucose 
cotransporter 1 (SGLT1) protein found in diabetic and 
hypertensive patients which plays a key role in xerostomia 
through salivary water reabsorption in salivary ducts (Sab-
ino-Silva et al. 2013), Table 1. SGLT1 was mostly increased 
in the luminal membrane of ductal cells and was inversely 
proportional to salivary flow (Sabino-Silva et al. 2013). 
These findings could play a pivotal role for future studies 
involving SGLT1 inhibitors-based treatments for xerostomia 
in diabetic and hypertensive patients.
Nitric oxide synthase and tetrahydrobiopterin Protein 
(NOS‑BH4)
Nitric oxide (NO), a major player in healthy salivary 
glands physiology, is synthesized by nitric oxide synthase 
(NOS) which comes in neuronal (nNOS) and endothelial 
(eNOS) forms. NOS is typically found dispersed in the 
neural terminals within the salivary glands and also in the 
ductile system which contains nNOS in the apical mem-
brane of the excretory and striated ducts, the cytoplasm 
of granular convoluted tubules and in the cytoplasm 
of excretory and striated ducts (Lomniczi et al. 1998). 
NO’s role in salivary secretion consists in the regulation 
of cGMP production. Upon salivary gland muscarinic 
receptor activation, intracellular calcium increases and 
stimulates the production of NOS, that catalyzes the for-
mation of NO, ultimately leading to the generation of 
cyclic guanosine monophosphate cGMP which in turn 
opens ion channels (Putney 1983; Dawson et al. 2001) 
to initiate the secretory process (Sakai et al. 2002). NOS 
activity was found to be crucial for the regulation of aqua-
porin 5 (AQP5), a major protein involved in the salivary 
secretion (Lasisi et al. 2019). NOS requires tetrahydrobi-
opterin (BH4), a cofactor of NOS, as its catalytic activity 
depends on a BH4-dependent dimerization (Förstermann 
and Sessa 2012). DM rat submandibular eNOS and nNOS 
protein expression as well as their enzymatic activity were 
shown to be decreased. BH4 was reported to be downreg-
ulated in DM rat submandibular glands and its decrease 
directly correlated with the degree of dimerization of 
NOS (Stewart et al. 2016), Table 1. Consequently, BH4 
insufficiency leads to n/e NOS uncoupling and reduced 
enzymatic activity; n/e NOS activity represents a criti-
cal signaling knot for adjusting salivary gland function 
(Stewart et al. 2016). These data encourage research to 
determine the mechanisms underpinning the decrease of 
NOS-BH4 protein expression as a trigger for the develop-
ment of hyposalivation in diabetes- induced xerostomia. 
Understanding the role of NOS-BH4 pathway may reveal 
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Table 1  Examples of studies in which salivary proteins have been measured in DM
A/D Atrophy and degeneration of salivary glands, N.A. not available, T1DM type 1 diabetes mellitus, T2DM type 2 diabetes mellitus, SGLT1 
sodium-glucose cotransporter 1, SMG submandibular glands, PG parotid glands, I.V intravenous, NOS-BH4 nitric oxide synthase-tetrahydro-
biopterin, STZ streptozotocin, BMP7 bone morphogenetic protein 7, CSP1 common salivary protein 1, LG labial glands, AQP aquaporin, M3R 
muscarinic M3 receptor, HSP60 heat shock protein 60, EGF epidermal growth factor, CK5 cytokeratin 5, CK7 cytokeratin 7, Bcl2 B cell lym-
phoma 2, PCNA proliferating cell nuclear antigen, Bax Bcl2-associated X protein, Casp3 caspase-3
a Type of diabetes not specified




Amylase Saliva Increase N.A Decrease T1DM and T2DM patients López et al. (2003), Aydin (2007), Malathi et al. 
(2013), Priya et al. (2016), Lima-Aragão et al. 
(2016), Lodgotra et al. (2016), Abd-Elraheem 
et al. (2017), Tiongco et al. (2019), and Kheir-
mand Parizi et al. (2019)
Decrease Tenovuo et al. (1986), Newrick et al. (1991), 
Panchbhai et al. (2010), Prathibha et al. 
(2013), and Indira et al. (2015)
SGLT1 SMG Increase N.A Decrease T1DM Alloxan Rats (I.V) Sabino-Silva et al. (2013)
PG
NOS-BH4 SMG Decrease Yes Decrease T1DM STZ Rats Stewart et al. (2016)
PG
BMP7 SMG N.S No Decrease T1DM STZ Rats Izumi et al. (2008)
PG Decrease Yes
CSP1 Serum Increase N.A N.A DM  patientsa Wang et al. (2016)
Saliva Zhang et al. (2020)
Statherin Saliva Decrease N.A N.A T1DM patients Caseiro et al. (2013)
PG T2DM patients Isola et al. (2012)
SMG Isola et al. (2011b)
LG Isola et al. (2011a)
AQP1 SMG Decrease Yes Decrease T1DM STZ Rats Cui et al. (2021)
AQP5 SMG-PG Wang et al. (2011), Bhattarai et al. (2017), 
Biswas et al. (2018), Cui et al. (2021)
AQP8 SMG Cui et al. (2021)
M3R SMG Decrease Yes Decrease T1DM STZ Rats Watanabe et al. (2001)
PG
HSP60 Saliva Increase N.A N.A T2DM patients Yuan et al. (2011)
Serum
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to be promising for developing new therapies for DM 
patients suffering from xerostomia.
Bone Morphogenetic Protein 7
Bone morphogenetic protein 7 (BMP7) is a protein in the 
transforming growth factor β superfamily, which has a multi-
functional role in the control of cell proliferation, differentia-
tion, growth and apoptosis (Cecchi et al. 2016). It has been 
shown that high levels of BMP7 mRNA play a significant 
role in secretory and degenerative changes in salivary glands 
in DM mice (Izumi et al. 2008). Reduced BMP7 levels in the 
parotid, but not submandibular gland, were associated with 
DM, Table 1. Histologically, remarkable degeneration with 
atrophy was also found in parotid gland, while degenera-
tion of submandibular gland was insignificant (Izumi et al. 
2008). To check if this is reversible with BMP7 therapy, 
BMP7 (50 and 100 µg/kg, i.v.) was administered in DM mice 
which led to substantial increase in salivary secretion, with 
ratio of recovery higher in parotid gland than in subman-
dibular gland (Izumi et al. 2008). These findings indicate 
that increased mRNA levels of BMP7 play a protective role 
in avoiding DM injury of salivary glands.
Common Salivary Protein 1
Common salivary protein 1 (CSP1, LOC124220; syno-
nyms: HRPE773, PRO1567), a salivary gland-specific pro-
tein, was notably increased in DM patients’ serum (Wang 
et al. 2016), Table 1. Indeed, immunostaining of CSP1 
in different exocrine/endocrine tissues from healthy sub-
jects was only detectable in salivary gland (Fig. 1). The 
mechanisms through which CSP1, a protein normally 
found in salivary secretions, translocates to the serum are 
unknown. The authors suggest that the same mechanisms 
by which serum proteins cross to the saliva could be acting 
in reverse. It has been shown that transport of molecules 
from serum to saliva occurs by transcellular (passive and 
active transport) and paracellular routes (ultrafiltration). 
Many cases involve detection of a biomarker for a specific 
disease in both the saliva and serum. In a recent study, the 
authors further investigated the salivary levels of CSP1 
in DM and healthy patients. They showed a significant 
up-regulation in CSP1 salivary levels in DM patients, suf-
ficient to be able to discriminate between DM and control 
groups (Zhang et al. 2020), Table 1. Detection of CSP1 
in salivary secretions may hold a great potential as a bio-
marker for DM patients’ diagnosis and screening as its 
non-invasiveness, and consequent safety and ease of col-
lection constitute significant advantages over blood-based 
diagnostics.
Statherin protein
Statherin is an important salivary protein in humans that is 
encoded by the STATH gene. It maintains the supersatu-
rated state of saliva by supporting high calcium and phos-
phate concentrations. High levels of calcium promote rem-
ineralization, recalcification and stabilization of the tooth 
enamel and inhibit the formation of mineral accretions on 
tooth surfaces, while maintaining high levels of phosphate 
is crucial for buffering (De Sousa-Pereira et al. 2013). 
Statherin levels have been investigated in DM subjects 
in order to study its role in sustaining oral health (Izumi 
et al. 2015). A body of evidence indicate that statherin 
levels are decreased in saliva of T1DM children and in the 
secretory granules of parotid, submandibular and labial 
glands of DM patients (Isola et al. 2011b, a, 2012; Caseiro 
et al. 2013), Table 1. The data from those studies suggest 
Fig. 1  CSP1 is a salivary gland specific protein. Immunostaining 
of CSP1 in salivary (left), thyroid (center) and adrenal gland tissue 
(right) demonstrated that CSP1 stains specifically and exclusively 
salivary glands and not the other two tissues rendering it a salivary 
gland-specific protein. Wang et  al., 2016. Journal of clinical labora-
tory analysis. Taken from: https:// doi. org/ 10. 1002/ jcla. 21963 (Wang 
et al. 2016)
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that insufficient levels of statherin could contribute to oral 
cavity complications in diabetes i.e. dental caries and oral 
infections. This encourages further investigation about 
statherin’s role as a marker of salivary dysfunction which 
is a major problem in DM patients encounter plus over-
all disease activity in T2DM explicitly. Salivary statherin 
levels in salivary glands of DM patients could serve as 
screening tool for diagnosis and prognosis of DM patients.
Aquaporins
AQPs have been a center of investigation for their role in 
the pathogenesis of diabetic xerostomia (Bhattarai et al. 
2017; Biswas et al. 2018; Cui et al. 2021). They are also 
called water channels belonging to a larger family of major 
intrinsic proteins (He and Yang 2019). Aquaporins facilitate 
the transmission of water, small solutes and gas between 
cells. AQP1, AQP5 and AQP8 have been studied in diabetes-
induced xerostomia (Wang et al. 2011; Bhattarai et al. 2017). 
Three different groups of rats: control, STZ-induced DM 
and STZ-induced DM injected with insulin were selected 
in a study to show the correlation between hyposalivation 
in DM and the expression of aquaporins in the submandib-
ular salivary gland in addition to the therapeutic effect of 
insulin (Cui et al. 2021). Immunohistochemistry tests were 
performed to detect AQP expression and morphological 
changes. Results showed a significant decrease of expression 
of AQP1, AQP5, AQP8 accompanied by minor degeneration 
at the level of acini as well as architectural changes of the 
acinar cells in submandibular glands, resulting in decreased 
salivary secretion/flow in the DM mice, Table 1. In con-
trast, in both control and insulin-administered DM mice, 
submandibular glands’ AQPs expression were increased and 
the morphology of the gland was intact with normal salivary 
secretion (Cui et al. 2021). Another study was conducted 
to show a therapeutic effect of a herbal medicinal extract 
called Ixeris dentata (IXD) on hyposalivation induced by 
DM (Bhattarai et al. 2017). Results showed that T1DM rats 
that received a single oral spray of IXD extract under the 
tongue had a significant increase in the expression of AQP5 
in salivary gland acinar and ductal cells and consequently 
increased salivary gland secretion (Bhattarai et al. 2017). 
Effect of low-level laser therapy (LLLT) on the membrane 
distribution of AQP5 in xerostomia DM patients was also 
investigated (Biswas et al. 2018). The expression of AQP5 
had been altered due to supersaturated intracellular  Ca2+ 
and the ER stress caused by hyperglycemia. LLLT upregu-
lated the membrane redistribution and expression of AQP5 
and increased salivary secretion in DM rats (Biswas et al. 
2018). These findings suggest that aquaporin-based thera-
pies may play a significant role in alleviating xerostomia in 
DM patients.
Muscarinic Receptors
Saliva’s secretion and release depends on parasympathetic 
stimulation. A study has been conducted to demonstrate 
whether the decrease in salivary secretion in DM is solely 
due to water loss or whether it is due to a major involve-
ment of muscarinic receptors (Watanabe et al. 2001). Saliva 
secretion was measured in control and STZ-induced DM 
rats. Under no stimulation, control and DM rats given water 
ad libitum manifested similar whole saliva amounts. Upon 
pilocarpine treatment, a muscarinic acetylcholine ago-
nist, the secretion of saliva in both groups increased, but 
this increase was two- to three-fold higher in control. The 
same pilocarpine treatment was given to DM rats after 6 h 
of water restriction and this time it only slightly increased 
the salivary secretion in DM rats while salivary secretions 
were accentuated in control groups. These data indicate that 
salivary release in DM is gravely impacted by (presumably 
polyuria-induced) water loss. Pilocarpine-induced salivary 
release showed no dose-dependent correlation in DM rats 
(in contrast with controls) and in fact was significantly 
decreased compared to controls upon high doses indicating 
that DM rats have a lowered susceptibility for muscarinic 
receptor simulation. To further investigate the specificity and 
affinity of muscarinic receptors binding sites, radiolabeling 
assays were conducted at the level of parotid and subman-
dibular glands. Results showed (1) a decrease in binding 
site of muscarinic receptor in the parotid gland membranes 
(2) a decrease in affinity of muscarinic receptor in the sub-
mandibular gland membranes (3) a decrease in drug suscep-
tibility for muscarinic receptor agonists in the DM versus 
control rats (Watanabe et al. 2001), Table 1. The decrease in 
muscarinic receptor activity was accompanied by histomor-
phological changes and degeneration at the level of acinar 
cells and the authors believe that there is a direct correlation 
between those factors (Watanabe et al. 2001). The pathway 
pertaining to muscarinic receptor changes in hyperglycemic 
conditions and their effect on salivary secretion is illustrated 
in Fig. 2.
Heat shock protein 60 (Hsp60)
Hsp60 belongs to the molecular chaperone family, and is 
activated upon endogenous or exogenous stress signals to 
prevent cellular injury (Basset et al. 2020b). As aforemen-
tioned, DM patients present a higher risk of developing 
oral-related diseases, including salivary gland diseases, thus 
the circulating levels of Hsp60 in serum and saliva of DM 
patients might be expected to be elevated in response. Hsp60 
levels were measured (Yuan et al. 2011) and quantification 
revealed a significant increase in the protein expression of 
Hsp60 in both the serum and saliva of DM patients com-
pared with healthy individuals, Table 1. Hsp60’s levels in 
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saliva were positively correlated with those in the serum, 
while serum Hsp60 was 16-fold higher than the ones in 
saliva. While the mechanism of action of the translocation of 
the Hsp60 in the saliva is unknown, it is speculated that this 
phenomenon may be attributed to their extracellular-release 
via the exosomal pathway. The correlation between serum 
and saliva Hsp60 in DM patients renders Hsp60 a candidate 
for biomarker studies and for screening of diabetic patients 
in routine monitoring.
Alterations of fetal salivary gland protein expression 
in the diabetic milieu
DM can have deleterious effects on salivary glands func-
tion in adults. A question comes to mind on whether this 
could be reciprocated pre-nataly where diabetic environ-
ment could modulate the physiology and morphology of 
the emrbyo’s salivary glands. Thus, we wanted to elabo-
rate further on this topic as we consider it an important 
area of research from here on and wanted to highlight the 
major exacerbation of pre-natal diabetic environment on 
the function and architecture of emrbyonic salivary glands. 
Indeed, the effects of maternal DM on the submandibu-
lar glands of the off-spring rats have been investigated (El 
Sadik et al. 2018). DM exhibited degenerative effects in 
the gland morphology and function, altering their secre-
tory activity affecting oral and digestive health. The sub-
mandibular glands of the offspring of STZ female rats 
were assessed at two and four weeks after birth. Several 
genes involved in cell growth, differentiation and cellular 
apoptosis were altered: epidermal growth factor (EGF), 
cytokeratin 5 (CK5), CK7, AQP5 and B cell lymphoma 2 
(Bcl2) were downregulated; in contrast, Bcl2-associated 
X protein (Bax) was up-regulated (El Sadik et al. 2018), 
Table 1. Caspase-3 is the downstream effector of mitochon-
drial-cytochrome c cellular apoptosis pathway, involving 
Bax. Caspase-3 was reported increased along with Bax in 
salivary glands of the offspring of DM groups resulting 
in apoptosis and therefore loss of salivary gland function 
(Fig. 3). PCNA, a cell proliferation marker, was shown 
Fig. 2  Salivary secretion pathway in DM. Consistent hyperglyce-
mia will lead to an increased state of oxidative stress that ultimately 
impacts salivary secretion and flow. In diabetes, M3R’s binding sites, 
affinity and drug susceptibility are decreased which in turn result in 
a lower intracellular Ca2 + ([Ca2 +]i). Combined with a decrease in 
BH4, a cofactor necessary for the dimerization of uNOS into cNOS, 
NOS activation is decreased paralleled by a reduction in NO catalyza-
tion and AQP5 translocation. cGMP production is decreased due to 
NO deficiency and fails to open ion channels (i.e. K + channels, Cl- 
channels, Na + /K + pumps) to initiate salivary secretion. The obstruc-
tion of this pathway in DM leads to reduced salivary flow, secretions 
and histomorphological changes accompanied by acinar cells degen-
eration. Administration of pilocarpine, a cholinergic agonist, slightly 
alleviates those effects, whereas insulin, LLLT and IXD work directly 
on recruiting and upregulating AQP5 to reverse those effects. M3R, 
Muscarinic M3 receptor; [Ca2 +]i, intracellular calcium; uNOS, 
uncoupled nitric oxide synthase; cNOS, coupled nitric oxide syn-
thase; NO, nitric oxide; cGMP, cyclic guanylate monophosphate; 
AQP5, aquaporin 5; LLLT, low-level laser therapy; IXD, ixeris den-
tata
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to be reduced in the salivary glands of the offspring of 
DM groups. Ultimately salivary gland activity was lost 
altogether, presumably as a result of increased apoptosis 
and reduced growth (Fig. 4). These results demonstrate 
that these genes play a significant role in saliva secretion, 
glands tumorigenesis, growth of normal oral flora and oral 
microbes, with decreased protein synthesis and produc-
tion of xerostomia and dental caries. Moreover, damage of 
normal glandular morphology, significant increase in fibro-
sis and stagnation of secretory granules were found with 
atrophic changes in the acinar cells (El Sadik et al. 2018). 
Decrease in the number of secretory granules is consistent 
with the role of DM in reducing the human gland secretory 
activity. All these findings prove that intrauterine diabetic 
milieu affects the growth of the gland and its prenatal and 
postnatal architecture and function.
Conclusion
Nowadays, studies revolving around DM acknowledge the 
tight association between diabetes and oral-related compli-
cations. Salivary glands dysfunction in the diabetic milieu 
has been a subject of interest as of late, as studies seem to 
suggest the importance of studying key salivary proteins 
in DM patients. Understanding the underlying mechanism 
responsible for the deregulation of salivary proteins is of 
crucial importance as it may be directly associated with the 
pathogenesis of diabetes-related salivary gland diseases. 
Additionally, target-based therapy of salivary specific pro-
teins for restoring diabetes-induced salivary gland injury 
and degeneration should be further examined and tested. 
Diabetes-induced alterations of salivary proteins positively 
correlate with patients’ health profile. In this review, we 
propose that the detection of key salivary proteins may be 
Fig. 3  Caspace-3-mediated apoptosis increases in postnatal offspring 
submandibular glands of diabetic rats. A and C (2 weeks (2w) post-
natal control and 4  weeks (4w) postnatal control groups) showing 
negative caspase-3 reaction. B (2w diabetic group) showing positive 
caspase-3 reaction in the form of brown discoloration of the cellular 
acini. D (4w diabetic group) showing very strong positive caspase-3 
reaction. (Caspase-3 × 1000). El Sadik et al., 2018. PLoS One. Taken 
from: https:// doi. org/ 10. 1371/ journ al. pone. 02053 72 (El Sadik et  al. 
2018)
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the basis of developing non-invasive means of diagnosis 
and prognosis during routine screening of patients with the 
notion in mind that extensive research correlating salivary 
specific markers with serum glucose levels in DM patients 
is required to achieve the aforementioned results.
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